Relationship between Stress Shielding and Optimal Femoral Canal Contact Regions for Short, Tapered-Wedge Stem Analyzed by 2D and 3D Systems in Total Hip Arthroplasty.
Maeda T, Nakano M, Nakamura Y*, Momose T, Sobajima A, Takahashi J, Nakata K, Nawata M.
J Clin Med, 2023年, 査読無し
12, 3138
Nitric oxide is associated with fracture risk in Japanese women.
Shiraki M, Kuroda T, Nakano M, Nakamura Y*, Saito M, Urano T.
PLoS One, 2023年, 査読無し
18, e0280854
Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration.
Kobayakawa T, Miyazaki A, Kanayama Y, Hirano Y, Takahashi J, Suzuki T, Nakamura Y*.
Mod Rheumatol., 2023年, 査読無し
23, 96, 103
Distinct dietary risk factors for incident osteoporotic fractures in early and late postmenopausal phase women.
Nakano M, Uenishi K, Nakamura Y*, Takahashi J, Shiraki M
J Bone Miner Metab, 2023年, 査読無し
41, 227, 238
Clinical and molecular features of patients with COL1-related disorders: Implications for the wider spectrum and the risk of vascular complications.
Takeda R, Yamaguchi T, Hayashi S, Sano S, Kawame H, Kanki S, Taketani T, Yoshimura H, Nakamura Y, Kosho T.
Am J Med Genet, 2022年, 査読無し
188A, 2560, 2575
Verification of efficacy and safety of ibandronate or denosumab for postmenopausal osteoporosis after 12-month treatment with romosozumab as sequential therapy: The prospective VICTOR study.
Kobayakawa T, Miyazaki A, Takahashi J, Nakamura Y*.
BONNE, 2022年, 査読無し
162, 116480
Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration.
Kobayakawa T, Miyazaki A, Kanayama Y, Hirano Y, Takahashi J, Suzuki T, Nakamura Y*.
Mod Rheumatol., 2022年, 査読無し
roac014.
Effects of romosozumab with and without active vitamin D analog supplementation for postmenopausal osteoporosis.
Kobayakawa T, Miyazaki A, Takahashi J, Nakamura Y*.
Clin Nutr ESPEN, 2022年, 査読無し
48, 267, 274
Peficitinib improves bone fragility by recovering bone turnover imbalance in arthritic mice.
Sugawara S, Hanaoka K, Emori T, Takeshita N, Fujii Y, Nakano M, Suzuki T, Takahashi J, Nakamura Y*.
J Pharmacol Sci., 2022年, 査読無し
148, 134, 141
Efficacy of romosozumab for osteoporosis in a patient with osteogenesis imperfecta: A case report.
Uehara M, Nakamura Y*, Nakano M, Miyazaki A, Suzuki T, Takahashi J.
Mod Rheumatol Case Rep., 2022年, 査読無し
6, 128, 133
Efficacy of denosumab therapy for a 12-year-old woman with Williams syndrome with osteoporosis and history of fractures: A case report.
Uehara M, Nakamura Y*, Suzuki T, Nakano M, Takahashi J.
J Med Case Rep, 2021年, 査読無し
15, 594
Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis.
Uehara M, Nakamura Y*, Suzuki T, Nakano M, Takahashi J.
J Clin Med, 2021年, 査読無し
10, 5420
Associations of LRP5 and MTHFR Gene Variants with Osteoarthritis Prevalence in Elderly Women: A Japanese Cohort Survey Randomly Sampled from a Basic Resident Registry.
Nakano M, Yui H, Kikugawa S, Tokida R, Sakai N, Kondo N, Endo N, Haro H, Shimodaira H, Suzuki T, Kato H, Takahashi J, Nakamura Y*.
Ther Clin Risk Manag., 2021年, 査読無し
17, 1065, 1073
MTHFR gene C677T polymorphism predicts progression of spinal osteoarthritis.
Nakano M, Nakamura Y*, Urano T, Miyazaki A, Suzuki T, Watanabe K, Takahashi J, Shiraki M
J Clin Endocrinol Metab., 2021年, 査読無し
dgab591.
Short- to Mid-Term Clinical Outcomes of Posterior-Stabilized Cementless Total Knee Arthroplasty with Trabecular Metal Components.
Momose T, Nakamura Y*, Nakano M, Maeda T, Morioka S, Sobajima A, Nakatsuchi Y, Takahashi J, Nawata M
Ther Clin Risk Manag., 2021年, 査読無し
17, 809, 816
Denosumab versus romosozumab for postmenopausal osteoporosis treatment.
Kobayakawa T, Miyazaki A, Saito M, Suzuki T, Takahashi J, Nakamura Y*
Sci Rep, 2021年, 査読無し
11, 11801
Zinc Pharmacotherapy for Elderly Osteoporotic Patients with Zinc Deficiency in a Clinical Setting
Nakano M, Nakamura Y*,Miyazaki A, Takahashi J
Nutrients, 2021年, 査読無し
13, 1814
Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
Kobayakawa T, Suzuki T, Nakano M, Saito M, Miyazaki A, Takahashi J, Nakamura Y*
Bone Rep, 2021年, 査読無し
14, 101068
Reference values for bone metabolism in a Japanese cohort survey randomly sampled from a basic elderly resident registry.
Tokida R, Uehara M, Nakano M, Suzuki T, Sakai N, Ikegami S, Takahashi J, Nakamura Y, Kato H
Sci Rep, 2021年, 査読無し
11, 7822
Pentosidine and carboxymethyl-lysine associate differently with prevalent osteoporotic vertebral fracture and various bone markers
Nakano M, Nakamura Y*, Suzuki T, Miyazaki A, Takahashi J, Saito M, Shiraki M
Sci Rep, 2020年, 査読無し
10, 22090
Implications of historical height loss for prevalent vertebral fracture, spinal osteoarthritis, and gastroesophageal reflux disease
Nakano M, Nakamura Y*, Suzuki T, Kobayashi T, Takahashi J, Shiraki M
Sci Rep, 2020年, 査読無し
10, 19036
Same-side insufficiency fractures of the tibia and femur after denosumab discontinuation: A case report
Koiwai H, Kamimura M, Nakamura Y*, Takahashi J, Taguchi A
Mod Rheumatol Case Rep, 2020年, 査読無し
5, 178, 181
Spinal osteoarthritis is associated with stature loss independently of incident vertebral fracture in postmenopausal women.
Nakano M, Nakamura Y*, Suzuki T, Takahashi J, Shiraki M
Spine (Phila Pa 1976), 2020年, 査読無し
45, E1400, E1404
Differences in bone mineral density and bone turnover markers between subjects with and without diffuse idiopathic skeletal hyperostosis.
Uehara M, Takahashi J, Ikegami S, Tokida R, Nishimura H, Sakai N, Nakamura Y, Kato H
Spine (Phila Pa 1976), 2020年, 査読無し
45, E1677, E1681
The first experience of denosmab therapy on patients with Ehlers-Danlos syndrome and osteoporosis: Detailed observation of two patients.
Yasukawa S, Uehara M, Suzuki T, Nakano M, Kosho T, Nakamura Y*, Takahashi J
Mod Rheumatol Case Rep, 2020年, 査読無し
44210
Remarkable loss of bone mineral density in 6 months after denosumab discontinuation: a case report
Maezumi Y, Kamimura M, Nakamura Y*, Takahashi J
Mod Rheumatol Case Rep, 2020年, 査読無し
4, 218, 221
骨粗鬆症対策. 特集 リウマチと整形外科
中村幸男、鈴木孝子
関節外科, 2020年, 査読無し
39, 44, 49
スクレロスチン分泌低下に伴う大腿骨近位部骨折予防戦略
中村幸男、鈴木孝子
大和証券ヘルス財団研究業績集, 2020年, 査読無し
43, 152, 154
Efficacy of denosumab therapy after alendronate treatment for a 66-year-old woman with Camurati-Engelmann disease and osteoporosis: A case report
Uehara M, Nakamura Y*, Suzuki T, Takahashi J, Kato H
Mod Rheumatol Case Rep, 2020年, 査読無し
4, 131, 134
ZMAT2, a newly-identified potential disease-causing gene in congenital radioulnar synostosis, modulates BMP signaling
Suzuki T, Nakano M, Komatsu M, Takahashi J, Kato H, Nakamura Y*
Bone, 2020年, 査読無し
136, 115349
Two adipocytokines, leptin and adiponectin, independently predict osteoporotic fracture risk at different bone sites in postmenopausal women
Nakamura Y*, Nakano M, Suzuki T, Sato J, Kato H, Takahashi J, Shiraki M
Bone, 2020年, 査読無し
137, 115404
Efficacy of 4-year denosumab treatment alone or in combination with teriparatide in Japanese postmenopausal osteoporotic women
Suzuki T, Nakamura Y*, Kato H
Mod Rheumatol, 2019年, 査読無し
29, 676, 681
Efficacy of denosumab therapy for osteoporosis-pseudoglioma syndrome with osteoporosis: A case report
Miyazawa S, Nakamura Y*, Suzuki T, Kato H
Mod Rheumatol Case Rep, 2019年, 査読無し
3, 45, 48
The Shisa3 knockout mouse exhibits normal bone phenotype
Murakami K, Zhifeng H, Suzuki T, Kobayashi Y, Nakamura Y*
J Bone Miner Metab, 2019年, 査読無し
37, 967, 975
Additive effects of eldecalcitol in poorly responding long-term bisphosphonate treatment for osteoporosis
Kamimura M, Ikegami S, Mukaiyama K, Koiwai H, Nakamura Y*, Taguchi A, Kato H
Osteoporos Sarcopenia, 2019年, 査読無し
5, 57, 61
Effects of monthly minodronate with or without eldecalcitol addition in osteoporosis patients with rheumatoid arthritis: An 18-month prospective study
Suzuki T, Nakamura Y*, Kato H
Osteoporos Sarcopenia, 2019年, 査読無し
5, 122, 127
Unexpected rapid increase in bone mineral density by bisphosphonate therapy after multiple spinal fractures: A case report
Koiwai H, Kamimura M, Takahashi J, Nakamura Y*, Kato H
J Med Case Rep, 2019年, 査読無し
13, 288
Efficacy of denosumab therapy for a 21-year-old woman with Prader-Willi syndrome, osteoporosis and history of fractures: a case reportUehara M, Nakamura Y*, Takahashi J, Suzuki T, Iijima M, Arakawa Y, Ida K, Kosho T, Kato H
Ther Clin Risk Manag, 2019年, 査読無し
15, 303, 307, 10.2147/TCRM.S186855
薬物療法による骨粗鬆症性骨折の予防と対策
中村幸男
日本骨粗鬆症学会雑誌, 2018年, 査読無し
4, 188, 189
ステロイド性骨粗鬆症に対するdenosumabの有用性. 特集 ステロイド性骨粗鬆症のupdate
中村幸男
リウマチ科, 2018年, 査読無し
60, 603, 608
Efficacy of teriparatide and denosumab combination treatment in a patient with atypical femoral fracture and Behçet's disease: A case report and review of the literature
Uehara M, Nakamura Y*, Takahashi J, Isobe F, Ikegami S, Suzuki T, Uchiyama S, Kamimura M, Kato H
Mod Rheumatol Case Rep, 2018年, 査読無し
2, 92, 96
Novel method for evaluation of hindfoot alignment in weight-bearing position using laser beam
Ohnishi T, Hida M, Nakamura Y*, Wada C
J Phys Ther Sci, 2018年, 査読無し
30, 474, 478
Denosumab significantly improves lumbar spine bone mineral density more in treatment-naïve than in long-term bisphosphonate-treated patients
Suzuki T, Nakamura Y*, Kamimura M, Kato H
Bone Rep, 2018年, 査読無し
8, 110, 114
Efficacy of denosumab for glucocorticoid-induced osteoporosis in an adolescent patient with Duchenne muscular dystrophy. A case report
Kumaki D, Nakamura Y*, Sakai N, Kosho T, Nakamura A, Hirabayashi S, Suzuki T, Kamimura M, Kato H
JBJS Case Connect, 2018年, 査読無し
8, e22
Determination of serum bone-related minerals during denosumab treatment in osteoporosis patients with rheumatoid arthritis
Suzuki T, Nakamura Y*, Kato H
Clin Nutr ESPEN, 2018年, 査読無し
26, 53, 56
Efficacy, safety, and compliance of ibandronate treatment for 3 years in postmenopausal Japanese women with primary osteoporosis
Suzuki T, Nakamura Y*, Kato H
Osteoporos Sarcopenia, 2018年, 査読無し
4, 69, 72
Efficacy of denosumab therapy for neurofibromatosis type I with osteoporosis and history of fractures: a case report
Uehara M, Nakamura Y*, Takahashi J, Kamimura M, Isobe F, Yamaguchi T, Kosho T, Uchiyama S, Suzuki T, Kato H
Ther Clin Risk Manag, 2018年, 査読無し
14, 1243, 1246
Suppression of methotrexate-induced elevations in the serum alanine aminotransferase level of patients with rheumatoid arthritis who had prior hepatitis B infection
Noguchi O, Nakamura Y, Kato H
Health, 2018年, 査読無し
10, 531, 541
Olfactomedin-like protein OLFML1 inhibits Hippo signaling and mineralization in osteoblastsMurakami K, Kikugawa S, Kobayashi Y, Uehara S, Suzuki T, Kato H, Udagawa N, Nakamura Y*
Biochem Biophys Res Commun, 2018年, 査読無し
505(2), 419, 425, 10.1016/j.bbrc.2018.09.112
Efficacy and Safety of Denosumab Therapy for Osteogenesis Imperfecta Patients with Osteoporosis-Case SeriesKobayashi T, Nakamura Y*, Suzuki T, Yamaguchi T, Takeda R, Takagi M, Hasegawa T, Kosho T, Kato H
J Clin Med, 2018年, 査読無し
7, E479, 10.3390/jcm7120479
Comparison of the effects of denosumab with either active vitamin D or native vitamin D on bone mineral density and bone turnover markers in postmenopausal osteoporosisSuzuki T, Nakamura Y*, Tanaka M, Kamimura M, Ikegami S, Uchiyama S, Kato H
Mod Rheumatol, 2018年, 査読無し
28(2), 376, 379, 10.1080/14397595.2017.1308454
Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatmentNakamura Y*, Kamimura M, Morikawa A, Taguchi A, Suzuki T, Kato H
Ther Clin Risk Manag, 2018年, 査読無し
14, 543, 549, 10.2147/TCRM.S156466
Pretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapyKamimura M, Taguchi A, Nakamura Y*, Koiwai H, Ikegami S, Uchiyama S, Kato H
Ther Clin Risk Manag, 2018年, 査読無し
14, 637, 642, 10.2147/TCRM.S154686
Significant improvement of bone mineral density by denosumab without bisphosphonate pre-treatment in glucocorticoid-induced osteoporosis.
Suzuki T, Nakamura Y*, Kato H
Mod Rheumatol, 2018年, 査読無し
28, 885, 889
Effects of denosumab on osteoporosis in three cases with anorexia nervosa and a review of the literature.
Isobe F, Nakamura Y*, Suzuki T, Kato H
Mod Rheumatol Case Rep, 2018年, 査読無し
2, 104, 106
Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
Kamimura M, Nakamura Y*, Ikegami S, Uchiyama S, Kato H, Taguchi A
Osteoporos Int, 2017年, 査読無し
28, 559, 566
Painful locking of the wrist in a patient with pseudoachondroplasia confirmed by COMP mutation
Ideta H, Uchiyama S, Hayashi M, Kosho T, Nakamura Y, Kato H
J Surg Case Rep, 2017年, 査読無し
2017, rjw216
Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study
Tanaka M, Nakamura Y*, Itoh S, Kato Y
Osteoporos Sarcopenia, 2017年, 査読無し
3, 37, 44
Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
Suzuki T, Nakamura Y*, Kamimura M, Ikegami S, Uchiyama S, Kato H
Osteoporos Sarcopenia, 2017年, 査読無し
3, 108, 111
A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitroMurakami K, Kobayashi Y, Uehara S, Suzuki T, Koide M, Yamashita T, Nakamura M, Takahashi N, Kato H, Udagawa N, Nakamura Y*
PLoS One, 2017年, 査読無し
12(7), e0181126, 10.1371/journal.pone.0181126
Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatmentNakamura Y*, Suzuki T, Kamimura M, Ikegami S, Mukaiyama K, Uchiyama S, Taguchi A, Kato H
Bone Res, 2017年, 査読無し
5, 17021, 10.1038/boneres.2017.21
Bony findings detected by MRI may reflect the pathophysiology of osteoarthritis with thumb carpometacarpal joint painKomatsu M, Kamimura M, Nakamura Y*, Mukaiyama K, Ikegami S, Hayashi M, Uchiyama S, Kato H
Int J Rheum Dis, 2017年, 査読無し
20, 1950, 1957, 10.1111/1756-185X.12781
Increased serum 25(OH)D3 levels in post-menopausal Japanese women with osteoporosis after 3-year bisphosphonate treatment
Nakamura Y*, Uchiyama S, Kamimura M, Ikegami S, Komatsu M, Kato H
Tohoku J Exp Med, 2017年, 査読無し
242, 241, 246
Efficacy of denosumab for osteoporosis in three female patients with osteogenesis imperfecta
Uehara M, Nakamura Y*, Takahashi J, Kamimura M, Ikegami S, Suzuki T, Uchiyama S, Yamaguchi T, Kosho T, Kato H
Tohoku J Exp Med, 2017年, 査読無し
242, 115, 120
Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D3 and alters values of parathyroid hormone, pentosidine, and bone metabolic markersKamimura M, Uchiyama S, Nakamura Y*, Ikegami S, Mukaiyama K, Kato H
Ther Clin Risk Manag, 2017年, 査読無し
13, 161, 168, 10.2147/TCRM.S120749
Alfacalcidol Increases the Therapeutic Efficacy of Ibandronate on Bone Mineral Density in Japanese Women with Primary OsteoporosisNakamura Y*, Suzuki T, Kamimura M, Ikegami S, Uchiyama S, Kato H
Tohoku J Exp Med, 2017年, 査読無し
241(4), 319, 326, 10.1620/tjem.241.319
Two-year clinical outcome of denosumab treatment alone and in combination with teriparatide in Japanese treatment-naive postmenopausal osteoporotic womenNakamura Y*, Suzuki T, Kamimura M, Ikegami S, Mukaiyama K, Uchiyama S, Taguchi A, Kato H
Bone Res, 2017年, 査読無し
5, 16055, 10.1038/boneres.2016.55
Value changes in bone turnover markers and bone mineral density using ibandronate in Japanese postmenopausal osteoporotic patients
Nakamura Y*, Ikegami S, Takanashi Y, Kamimura M, Uchiyama S, Kato H
J Nutr Disord Ther, 2016年, 査読無し
6, 188
Effects of denosumab treatment during early pregnancy - A case report
Isobe F, Nakamura Y*, Kamimura M, Uchiyama S, Kato H
J Nutr Disord Ther, 2016年, 査読無し
6, 189
Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate
Kamimura M, Nakamura Y*, Ikegami S, Komatsu M, Uchiyama S, Kato H
Osteoporos Sarcopenia, 2016年, 査読無し
2, 170, 174
Association of self-reported height loss and kyphosis with loss of teeth in Japanese elderly
Taguchi A, Kamimura M, Sugino N, Uchida K, Kitamura Y, Ikegami S, Nakamura Y, Uchiyama S, Kato H
Oral Health Dent Manag, 2016年, 査読無し
15, 69, 74
原発性骨粗鬆症に対する12カ月間のイバンドロネート注射製剤とエルデカルシトール併用治療の有効性と安全性の検討
田中 瑞栄; 中村 幸男; 伊藤 聰一郎; 島本 周治; 加藤 義治
日本骨粗鬆症学会雑誌 = The journal of Japan Osteoporosis Society, 2016年, 査読無し
2(3), 275, 283
Risk factors of adjacent vertebral collapse after percutaneous vertebroplasty for osteoporotic vertebral fracture in postmenopausal womenTakahara K, Kamimura M, Moriya H, Ashizawa R, Koike T, Hidai Y, Ikegami S, Nakamura Y*, Kato H
BMC Musculoskelet Disord, 2016年, 査読無し
17, 12, 10.1186/s12891-016-0887-0
The dynamin inhibitor dynasore inhibits bone resorption by rapidly disrupting actin rings of osteoclastsThirukonda GJ, Uehara S, Nakayama T, Yamashita T, Nakamura Y, Mizoguchi T, Takahashi N, Yagami K, Udagawa N, Kobayashi Y
J Bone Miner Metab, 2016年, 査読無し
34, 395, 405, 10.1007/s00774-015-0683-1
Clinical implications of hip flexion in the measurement of spinal bone mineral densityIkegami S, Kamimura M, Uchiyama S, Nakamura Y, Mukaiyama K, Kato H
J Clin Densitom, 2016年, 査読無し
19, 270, 276, 10.1016/j.jocd.2015.11.002
Associations of self-reported height loss and kyphosis with vertebral fractures in Japanese women 60 years and older: a cross-sectional surveyKamimura M, Nakamura Y, Sugino N, Uchiyama S, Komatsu M, Ikegami S, Kato H, Taguchi A
Sci Rep, 2016年, 査読無し
6, 29199, 10.1038/srep29199
Delayed wound healing after tooth extraction and self-reported kyphosis in Japanese men and womenTaguchi A, Kamimura M, Nakamura Y*, Sugino N, Ichinose A, Maezumi H, Fukuzawa K, Ashizawa R, Takahara K, Gushiken S, Mukaiyama K, Ikegami S, Uchiyama S, Kato H
Sci Rep, 2016年, 査読無し
6, 36309, 10.1038/srep36309
Bone alterations in painful osteoarthritic shoulder
Komatsu M, Nakamura Y*, Kamimura M, Ikegami S, Mukaiyama K, Uchiyama S, Kato H
J Case Rep, 2015年, 査読無し
5, 84, 87
Goniothalamin enhances TRAIL-induced apoptosis in colorectal cancer cells through DR5 upregulation and cFLIP downregulation
Sophonnithiprasert T, Nilwarangkoon S, Nakamura Y, Watanapokasin R
Int J Oncol, 2015年, 査読無し
47, 2188, 2196
Antiproliferation and apoptosis induction in colorectal cancer cells by goniothalamin
Sophonnithiprasert T, Mahabusarakam W, Nakamura Y, Watanapokasin R
J Med Assoc Thai, 2015年, 査読無し
98(Suppl9), S146, 151
Changes in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: A short-term study
Nakamura Y*, Kamimura M, Ikegami S, Mukaiyama K, Uchiyama S, Taguchi A, Kato H
BMC Endocr Disord, 2015年, 査読無し
15, 81
Eldecalcitol, in combination with bisphosphonate, is effective for treatment of Japanese osteoporotic patients
Mukaiyama K, Uchiyama S, Nakamura Y, Ikegami S, Taguchi A, Kamimura M, Kato H
Tohoku J Exp Med, 2015年, 査読無し
237, 339, 343
A case series of pregnancy- and lactation- associated osteoporosis and a review of the literature
Nakamura Y*, Kamimura M, Ikegami S, Mukaiyama K, Komatsu M, Uchiyama S, Kato H
Ther Clin Risk Manag, 2015年, 査読無し
11, 1361, 1365
Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a
Kobayashi Y, Thirukonda GJ, Nakamura Y, Koide M, Yamashita T, Uehara S, Kato H, Udagawa N, Takahashi N
Biochem Biophys Res Commun, 2015年, 査読無し
463, 1278, 1283
Expression profiles of human CCN genes in patients with osteoarthritis or rheumatoid arthritis
Komatsu M, Nakamura Y*, Maruyama M, Abe K, Watanapokasin R, Kato H
J Orthop Sci, 2015年, 査読無し
20, 708, 716
PCSK5 mutation in a patient with the VACTERL association
Nakamura Y*, Kikugawa S, Seki S, Takahata M, Iwasaki N, Terai H, Matsubara M, Fujioka F, Inagaki H, Kobayashi T, Kimura T, Kurahashi H, Kato H
BMC Res Notes, 2015年, 査読無し
8, 228
Osteoarthritis in the forefoot accompanied with joint pain is potentially associated with bone alterations
Nakamura Y*, Kamimura M, Uchiyama S, Komatsu M, Ikegami S, Kato H
Int J Diagn Imaging, 2015年, 査読無し
2, 64, 69
The skeletal muscle cross sectional area in long-term bisphosphonate users is smaller than that of bone mineral density-matched controls with increased serum pentosidine concentrations
Uchiyama S, Ikegami S, Kamimura M, Mukaiyama K, Nakamura Y, Nonaka K, Kato H
Bone, 2015年, 査読無し
75, 84, 87
Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover
Mukaiyama K, Kamimura M, Uchiyama S, Ikegami S, Nakamura Y, Kato H
Aging Clin Exp Res, 2015年, 査読無し
27, 413, 418
Factors that characterize bone health with aging in healthy postmenopausal women
Ikegami S, Uchiyama S, Nakamura Y, Mukaiyama K, Hirabayashi H, Kamimura M, Nonaka K, Kato H
J Bone Miner Metab, 2015年, 査読無し
33, 440, 447
Serum pentosidine levels after 3 years of bisphosphonate treatment in post-menopausal osteoporotic women
Hashidate H, Kamimura M, Ikegami S, Mukaiyama K, Uchiyama S, Nakamura Y*, Kato H
Endocr Res, 2015年, 査読無し
40, 172, 176
ビスホスホネート製剤の長期使用の問題点と休薬（drug holiday）-非定型大腿骨骨折を念頭に. 特集 進化する骨粗鬆症診療
内山茂晴、池上章太、中村幸男、加藤博之、三澤弘道
リウマチ科, 2014年, 査読無し
52, 567, 573
骨代謝マーカーによる骨癒合評価
上村幹男、中川浩之、池上章太、高原健治、外立裕之、中村幸男
整形・災害外科, 2014年, 査読無し
57, 629, 636
レーザー光を用いた距骨下関節アライメント計測法の開発
大西忠輔、中村幸男、和田健征、井野秀一、佐藤満、肥田光正、山口浩史、小澤恵美、三沢貴博、和田親宗、加藤博之、本田哲三
電子情報通信学会 信学技報, 2014年, 査読無し
3, 61, 65
Knee joint pain potentially due to bone alterations in a knee osteoarthritis patient
Komatsu M, Nakamura Y*, Kamimura M, Uchiyama S, Mukaiyama K, Ikegami S, Kato H
Am J Case Rep, 2014年, 査読無し
15, 534, 537
原発性骨粗鬆症患者に対するミノドロン酸水和物とリセドロネートにおける早期の臨床効果（骨代謝マーカー）関する比較検討
上村幹男、中村幸男
オステオポローシス・ジャパン, 2014年, 査読無し
22, 100, 101
膝関節内ガングリオンと脂肪腫を合併した極めて稀な一例
中村幸男、小林千益
中部整災誌, 2014年, 査読無し
57, 313, 314
Rapid bone destruction in a patient with knee osteoarthritis -A case report and review of the literature-
Komatsu M, Kamimura M, Nakamura Y*, Mukaiyama K, Ikegami S, Uchiyama S, Kato H
Clin Cases Miner Bone Metab, 2014年, 査読無し
11, 239, 242
Temporal and Spatial Expression Patterns of Bone Morphogenetic Protein 3 in Developing Zebrafish
Ito-Amano M, Nakamura Y*, Morisaki M, He X, Hayashi M, Watanapokasin R, Kato H
Open Rheumatol J, 2014年, 査読無し
8, 69, 72
The Pathophysiology and Progression of Hip Osteoarthritis Accompanied with Joint Pain are Potentially Due to Bone Alterations - Follow-up Study of Hip OA Patients
Kamimura M, Nakamura Y*, Uchiyama S, Ikegami S, Mukaiyama K, Kato H
Open Rheumatol J, 2014年, 査読無し
8, 46, 53
Case with Atypical Clinical Course Diagnosed as Osteoarthritis, Osteonecrosis, Subchondral Insufficiency Fracture, or Rapidly Destructive Coxopathy
Nakamura Y*, Kamimura M, Mukaiyama K, Ikegami S, Uchiyama S, Kato H
Open Rheumatol J, 2014年, 査読無し
8, 20, 23
Changes in Bone Turnover Markers and Fracture in Osteo¬porosis: A Review of the Literature
Nakamura Y*, Kamimura M, Ikegami S, Mukaiyama K, Uchiyama S, Kato H
Ann Orthop Rheumatol, 2014年, 査読無し
2, 1023
Tramadol/acetaminophen causes constipation more frequently in women with degenerative spinal disorders than in those with degenerative joint disorders
Kamimura M, Nakamura Y*, Ikegami S, Ichinose A, Uchiyama S, Kato H
Drugs Ther Perspect, 2014年, 査読無し
30, 149, 154
Significant differences of brain blood flow in patients with chronic low back pain and acute low back pain detected by brain SPECTNakamura Y, Nojiri K, Yoshihara H, Takahata T, Honda-Takahashi K, Kubo S, Sakatsume K, Kato H, Maruta T, Honda T
JOURNAL OF ORTHOPAEDIC SCIENCE, 2014年, 査読無し
19(3), 384, 389, 10.1007/s00776-014-0534-2
小児新鮮Monteggia骨折で橈骨頭観血的整復を要した6例の病態と手術成績
渡邉佳洋、保坂正人、中村幸男、伊坪敏郎、内山茂晴、加藤博之
日本肘関節学会誌, 2013年, 査読無し
20, 142, 145
進行性偽性リウマチ様異形成と変形性関節症の病態検討
中村幸男、多田秀穂、Ramida Watanapokasin、加藤博之
臨床雑誌整形外科, 2013年, 査読無し
64, 50
The Pathophysiology of Primary Hip Osteoarthritis may Originate from Bone Alterations
Kamimura M, Nakamura Y*, Ikegami S, Mukaiyama K, Uchiyama S, Kato H
Open Rheumatol J, 2013年, 査読無し
7, 112, 118
Joint pain undergoes a transition in accordance with signal changes of bones detected by MRI in hip osteoarthritis
Kamimura M, Nakamura Y*, Uchiyama S, Ikegami S, Kato H
Open Rheumatol J, 2013年, 査読無し
7, 67, 74
Apoptotic Induction of Skin Cancer Cell Death by Plant Extracts
Thuncharoen W, Chulasiri M, Nilwarangkoon S, Nakamura Y, Watanapokasin R
J Med Assoc Thai, 2013年, 査読無し
96(Suppl 1), S60, 64
軟骨特異的に発現するmiRNA140は内軟骨性骨化に重要でありBMPシグナルを制御するDnpepを標的とする
中村幸男、片桐岳信、加藤博之、小林竜也
中部整災誌, 2012年, 査読無し
55, 571, 572
受傷4日後に後骨間神経麻痺が明らかになった小児Monteggia骨折の1例
中村幸男、多田秀穂、中村恒一、加藤博之
日本肘関節学会誌, 2012年, 査読無し
19, 256, 258
microRNA140とそのホスト遺伝子であるWwp2は口蓋軟骨発生・形成に重要である
中村幸男、秋山治彦、多田秀穂、Ramida Watanapokasin、脇谷滋之、加藤博之
臨床雑誌整形外科, 2012年, 査読無し
63, 1286, 1287
進行性偽性リウマチ様異形成の原因と診断
中村幸男、加藤博之
臨床雑誌整形外科, 2012年, 査読無し
63, 1362
慢性痛のリハビリテーション
本田哲三、本田玖美子、高橋理夏、中村幸男、大房幸浩
ペインクリニック, 2012年, 査読無し
33, 1683, 1690
Sox9 is upstream of microRNA-140 in cartilage
Nakamura Y, He X, Kato H, Wakitani S, Kobayashi T, Watanabe S, Iida A, Tahara H, Warman ML, Watanapokasin R, Postlethwait JH
Appl Biochem Biotechnol, 2012年, 査読無し
166, 64, 71
Identification and functional analysis of Zranb2 as a novel Smad-binding protein that suppresses BMP signaling
Ohte S, Kokabu S, Iemura SI, Sasanuma H, Yoneyama K, Shin M, Suzuki S, Fukuda T, Nakamura Y, Jimi E, Natsume T, Katagiri T
J Cell Biochem, 2012年, 査読無し
113, 808, 814
Histone deacetylase-4 is required during early cranial neural crest development for generation of the zebrafish palatal skeleton
Delaurier A, Nakamura Y, Braasch I, Khanna V, Kato H, Wakitani S, Postlethwait JH, Kimmel CB
BMC Dev Biol, 2012年, 査読無し
12, 16
Craniofacial abnormalities result from knock down of nonsyndromic clefting gene, crispld2, in zebrafish
Yan Q, Chiquet BT, DeVault L, Warman ML, Nakamura Y, Swindell EC, Hecht JT
Genesis, 2012年, 査読無し
50, 871, 881
進行性偽性リウマチ様異形成の原因遺伝子であるWISP3の役割解明に向けた動物モデルアプローチ
中村幸男、脇谷滋之、田原秀晃、加藤博之、Matthew L. Warman
日本小児整形外科学会雑誌, 2011年, 査読無し
20, 1, 5
Wwp2 is essential for palatogenesis mediated by the interaction between Sox9 and mediator subunit 25
Nakamura Y, Yamamoto K, He X, Otsuki B, Kim Y, Murao H, Soeda T, Tsumaki N, Deng JM, Zhang Z, Behringer RR, Crombrugghe BD, Postlethwait JH, Warman ML, Nakamura T, Akiyama H
Nat Commun, 2011年, 査読無し
2, 251
α-Mangostin induces apoptosis in human chondrosarcoma cells through downregulation of ERK/JNK and Akt signaling pathway
Krajarng A, Nakamura Y, Suksamrarn S, Watanapokasin R
J Agric Food Chem, 2011年, 査読無し
59, 5746, 5754
Effects of α-mangostin on apoptosis induction of human colon cancer
Watanapokasin R, Jarinthanan F, Nakamura Y, Sawasjirakij N, Jaratrungtawee A, Suksamrarn S
World J Gastroenterol, 2011年, 査読無し
17, 2086, 2095
Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling
Nakamura Y, Inloes J, Katagiri T, Kobayashi T
Mol Cell Biol, 2011年, 査読無し
31, 3019, 3028
整形トピックス ゼブラフィッシュと整形外科分野
中村幸男
臨床雑誌整形外科, 2010年, 査読無し
61, 454
Zebrafish models for human FKRP muscular dystrophies
Kawahara G, Guyon JR, Nakamura Y, Kunkel LM
Hum Mol Genet, 2010年, 査読無し
19, 623, 633
Potential of xanthones from tropical fruit mangosteen as anti-cancer agents: Caspase-dependent apoptosis induction in vitro and in mice
Watanapokasin R, Jarinthanan F, Jerusalmi A, Suksamrarn S, Nakamura Y, Sukseree S, Uthaisang-Tanethpongtamb W, Ratananukul P, Sano T
Appl Biochem Biotechnol, 2010年, 査読無し
162, 1080, 1094
Temporal and spatial expression of CCN genes in zebrafish
Fernando CA, Conrad PA, Bartels CF, Marques T, To M, Balow SA, Nakamura Y*, Warman ML
Dev Dyn, 2010年, 査読無し
239, 1755, 1767
Normal growth and development in mice over-expressing the CCN family member WISP3
Nakamura Y*, Cui Y, Fernando C, Kutz WE, Warman ML
J Cell Commun Signal, 2009年, 査読無し
3, 105, 113
Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesis
Surmann-Schmitt C, Widmann N, Dietz U, Saeger B, Eitzinger N, Nakamura Y, Rattel M, Latham R, Hartmann C, von der Mark H, Schett G, von der Mark K, Stock M
J Cell Sci, 2009年, 査読無し
122, 3627, 3637
Unique roles of microRNA140 and its host gene WWP2 in cartilage biology
Nakamura Y, He X, Kobayashi T, Yan YL, Postlethwait JH, Warman ML
J Musculoskelet Neuronal Interact, 2008年, 査読無し
8, 321, 322
The CCN family member Wisp3, mutant in progressive pseudo rheumatoid dysplasia, modulates BMP and Wnt signaling
Nakamura Y, Weidinger G, Liang JO, Aquilina-Beck A, Tamai K, Moon RT, Warman ML
J Clin Invest, 2007年, 査読無し
117, 3075, 3086
Coordinate expression of BMP-2, BMP receptors and Noggin in normal mouse spine
Nakamura Y, Nakaya H, Saito N, Wakitani S
J Clin Neurosci, 2006年, 査読無し
13, 250, 256
Use of bone morphogenetic protein 2 and diffusion chambers to engineer cartilage tissue for the repair of defects in articular cartilage
Nawata M, Wakitani S, Nakaya H, Tanigami A, Seki T, Nakamura Y, Saito N, Sano K, Hidaka E, Takaoka K
Arthritis Rheum, 2005年, 査読無し
52, 155, 163
Meningioma arising in Werner syndrome confirmed by mutation analysis
Nakamura Y*, Shimizu T, Ohigashi Y, Itou N, Ishikawa Y
J Clin Neurosci, 2005年, 査読無し
12, 503, 506
Expression profiles and functional analyses of Wnt-related genes in human joint disorders
Nakamura Y, Nawata M, Wakitani S
Am J Pathol, 2005年, 査読無し
167, 97, 105
Microbubble-enhanced ultrasound exposure promotes uptake of methotrexate into synovial cells and enhanced antiinflammatory effects in the knees of rabbits with antigen-induced arthritis
Nakaya H, Shimizu T, Isobe K, Tensho K, Okabe T, Nakamura Y, Nawata M, Yoshikawa H, Takaoka K, Wakitani S
Arthritis Rheum, 2005年, 査読無し
52, 2559, 2566
The effects of heat on the biological activity of recombinant human bone morphogenetic protein-2
Ohta H, Wakitani S, Tensho K, Horiuchi H, Wakabayashi S, Saito N, Nakamura Y, Nozaki K, Imai Y, Takaoka K
J Bone Miner Metab, 2005年, 査読無し
23, 420, 425
Expression profiles of BMP-related molecules induced by BMP-2 or -4 in muscle-derived primary culture cells
Nakamura Y, Wakitani S, Saito N, Takaoka K
J Bone Miner Metab, 2005年, 査読無し
23, 426, 434
Embryonic stem cells form articular cartilage, not teratomas, in osteochondral defects of rat joints
Wakitani S, Aoki H, Harada Y, Sonobe M, Morita Y, Mu Y, Tomita N, Nakamura Y, Takeda S, Watanabe TK, Tanigami A
Cell Transplant, 2004年, 査読無し
13, 331, 336
Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: Two case reports
Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y, Horibe S
Cell Transplant, 2004年, 査読無し
13, 595, 600
関節軟骨の再生. 特集 現代医療の最前線（前篇）-再生医療と細胞療法-
脇谷滋之、中谷宏幸、中村幸男、縄田昌司
最新医学, 2003年, 査読無し
58, 261, 268
自己骨髄間葉系細胞移植による関節軟骨修復
中谷宏幸、脇谷滋之、縄田昌司、中村幸男
関節外科, 2003年, 査読無し
22, 63, 66
骨髄間葉系細胞移植による修復
脇谷滋之、縄田昌司、中村幸男、中谷宏幸
整形・災害外科, 2003年, 査読無し
46, 141, 146
Multiple periarticular osteosclerosis accompanied by joint destruction treated with bilateral total knee arthroplasty
Nakamura Y*, Nomura T, Nakajima S, Ito N, Wakitani S
J Arthroplasty, 2003年, 査読無し
18, 100, 104
Triple primary sarcoma in Werner syndrome with a novel mutation
Nakamura Y*, Shimizu T, Ishikawa Y, Matsumoto T, Sugimoto M, Goto M, Yoshimura Y, Wakitani S, Takaoka K
Rheumatology, 2003年, 査読無し
42, 1, 2
Temporal and spatial expression profiles of BMP receptors and Noggin during BMP-2 induced ectopic bone formation
Nakamura Y, Wakitani S, Nakayama J, Wakabayashi S, Horiuchi H, Takaoka K
J Bone Miner Res, 2003年, 査読無し
18, 1854, 1862
80歳以上の変形性股関節症に対する人工関節置換術 -機種の選択とソケット設置角-
野村隆洋、大久保守、百瀬敏充、中村幸男、倉石修吾、荻原伸英
臨床雑誌整形外科, 2001年, 査読無し
52, 649, 651
セメントレス人工膝関節全置換術の出血対策 -無輸血手術の工夫-
中村幸男、野村隆洋、大久保守、倉石修吾、荻原伸英
臨床雑誌整形外科, 2001年, 査読無し
52, 1133, 1134
高齢者の股関節症とその発症および進行因子としての腰椎後弯
野村隆洋、大久保守、百瀬敏充、中村幸男、倉石修吾、荻原伸英
臨床雑誌整形外科, 2001年, 査読無し
52, 1585, 1588
飯田市立病院における人工膝関節置換術の成績と現況
中村幸男、野村隆洋、大久保守、倉石修吾、荻原伸英
長野県医学会雑誌, 2001年, 査読無し
32, 7
急速破壊型股関節症を早期に診断するための臨床的指標
野村隆洋、大久保守、安達徹、中村幸男
臨床雑誌整形外科, 2000年, 査読無し
51, 403, 406
改良手技によるCharnley人工股関節10-16年経過例の成績 -オートロン90の摩耗計測とその限界
野村隆洋、大久保守、安達徹、中村幸男
臨床雑誌整形外科, 2000年, 査読無し
51, 1625, 1628
Extradigital glomus tumor causing para-Achilles tendon pain. -A case report-
Nakamura Y*, Nomura T, Ookubo M, Adati T, Harada D
Acta Orthop Belg, 2000年, 査読無し
66, 503, 506
複数病変を有する脊椎疾患の高位診断に磁気刺激検査が有効であった2例
中村幸男、江原宗平、上村幹夫、立岩裕、木下哲也、伊藤秀博、湯沢洋平、三沢朋子、高岡邦夫
東海脊椎外科, 1999年, 査読無し
13, 62, 63
原発性全身性アミロイド－シスを合併した慢性関節リウマチの1例
鳥海宏、宮坂忠篤、内山茂晴、中川浩之、中村幸男
骨粗鬆症・骨折研究会報, 1999年, 査読無し
6, 635, 636
Longitudinal median nerve conduction studies after endoscopic carpal tunnel release
Nakamura Y, Uchiyama S, Toriumi H, Nakagawa H, Miyasaka T
Hand Surg, 1999年, 査読無し
4, 145, 149
大腿部に発生した嚢胞状リンパ管腫の1例
中村幸男、清水富永、吉村康夫、高岡邦夫
臨床雑誌整形外科, 1998年, 査読無し
49, 1124, 1127
骨軟骨腫に似た画像所見を呈した脛骨腱靭帯付着部症の1例
中村幸男、清水富永、吉村康夫、赤羽努、高岡邦夫
臨床雑誌整形外科, 1998年, 査読無し
49, 1646, 1647
